Mentions
Extended reach
Total likes
Video views
AI synopsis
Overall, discussions show high interest and moderate engagement, with examples like mentions of the broad antiviral activity of peptidomimetic oligomers and their membrane-specific targeting mechanism. The tone ranges from celebratory acknowledgments to technical explanations, illustrating recognition of the research's significance and potential real-world applications.
Most discussions express positive recognition of the study's significance, highlighting its novelty and potential impact, though some innocuous comments suggest general acknowledgment rather than strong endorsement.
The discussions reflect high interest, with many posts emphasizing the broad antiviral activity and innovations in targeting viral membranes, demonstrating engagement with the scientific content.
Participants show moderate engagement by referencing specific aspects such as the membrane-specific mechanism and the therapeutic potential, along with personal contributions like PhD work and recognition of the authors.
The collective tone indicates that the publication is considered to have a notable impact on antiviral research and therapeutic development, especially given references to broad activity and resistance mitigation.
my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you ( even after you FIRED ME ) to complete some of this work. and obviously thank you to @mastvr1 & @christina_cunha for being a dream https://t.co/PEos2X00gS
ACS Infectious Diseases study "Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity" is generating attention. Congrats to lead author grad student Patrick Tate and Professor Kent Kirshenbaum! @aroralabnyu https://t.co/RMigXxoMtc
Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/IASm6EOZGv @ACSPublications https://t.co/o43Z0ZQSuO
@therustychemist @MaxwellBiosci Good question. Good answer: Here is our 2023 American Chemical Society publication on that topic: https://t.co/VF8TzpiuJ5 Alright, let's break this down. Imagine viruses as little invaders with either a protective coat, called an enveloped virus, or without one, which we'll
Biomimicry with bursting. Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine establishing an avenue for specificity that may enable the development of a new family of therapeutics capable of averting the rapid development of resistance. https://t.co/SvUZR3g7wN
Article Update! This article published in the August issue of ACS ID, shows the antiviral activity of AMP mimetic peptoids against an array of enveloped viruses, acting through a membrane-specific mechanism. https://t.co/WaIAYfq5sI @ACSBioMed #ACSInfectiousDiseases
This week longevity researcher Ryker Black introduces a new nasal spray designed to combat systemic inflammation, also known as inflammaging. The research is based on peer-reviewed studies highlighting inflammation's…
Novel molecules target and disable enveloped viruses like Zika and chikungunya by disrupting their membrane membranes, offering a potential new strategy for antiviral therapy with reduced resistance.
Scientists have developed a peptoid-based antiviral therapy that targets lipid components in virus membranes, disrupting enveloped viruses like Zika and chikungunya by interacting with phosphatidylserine, offering a…
RT @PatrickMTate: my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you…
RT @joshuamcclure: @therustychemist @MaxwellBiosci Good question. Good answer: Here is our 2023 American Chemical Society publication on t…
@therustychemist @MaxwellBiosci Good question. Good answer: Here is our 2023 American Chemical Society publication on that topic: https://t.co/VF8TzpiuJ5 Alright, let's break this down. Imagine viruses as little invaders with either a protective coat, called an enveloped virus, or without one, which we'll
Article Update! This article published in the August issue of ACS ID, shows the antiviral activity of AMP mimetic peptoids against an array of enveloped viruses, acting through a membrane-specific mechanism. https://t.co/WaIAYfq5sI @ACSBioMed #ACSInfectiousDiseases
Imitar las defensas del organismo para destruir virus envueltos https://t.co/u7nO7G4raO Más información: Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/ZDZdBP06vu ⬇️
Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity | ACS Infectious Diseases https://t.co/2u1v2vY9Rc
Biomimicry with bursting. Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine establishing an avenue for specificity that may enable the development of a new family of therapeutics capable of averting the rapid development of resistance. https://t.co/SvUZR3g7wN
RT @agingdoc1: Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/IASm6EOZGv @A…
Researchers have now developed a new antiviral treatment that ignores the rapidly mutating proteins on the surface of the virus and instead targets the lipids in the enveloped virus membrane, destroying its protective layer. https://t.co/5iqjyv0zyC
RT @agingdoc1: Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/IASm6EOZGv @A…
RT @agingdoc1: Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/IASm6EOZGv @A…
Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/IASm6EOZGv @ACSPublications https://t.co/o43Z0ZQSuO
ACS Infectious Diseases study "Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity" is generating attention. Congrats to lead author grad student Patrick Tate and Professor Kent Kirshenbaum! @aroralabnyu https://t.co/RMigXxoMtc
RT @PatrickMTate: my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you…
RT @PatrickMTate: my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you…
RT @PatrickMTate: my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you…
Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity https://t.co/u7NHvJw3Wn
RT @PatrickMTate: my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you…
my first first-author paper during my PhD is finally out! thank you so much @bryancmounce for letting me still bother you ( even after you FIRED ME ) to complete some of this work. and obviously thank you to @mastvr1 & @christina_cunha for being a dream https://t.co/PEos2X00gS
... 10.1021/acsinfecdis. 3c00063 https://youtu. be/MfwRbyJT8gY?si=Cc2yQ2fsWAc9MJDo "liposomes containing phosphatidylserine (PS) were markedly ...
' References. P M Tate et al, ACS Infect. Dis., 2023, 9, 1508 (DOI: 10.1021/acsinfecdis.3c00063). Ada McVean. Follow. Ada has been ...
They called these peptide-like molecules peptoids (ACS Infect. Dis. 2023, DOI: 10.1021/acsinfecdis.3c00063). Using AMPs against viruses isn't ...
doi: 10.1021/acsinfecdis.3c00063 (2023) (Epub ahead of print). Click here to view the press release. Top content. CRISPR for improving ...
doi.org/10.1021/acsinfecdis.3c00063. Be the first to rate this article. Posted in: Life Sciences News | Disease/Infection News. Comments (0).
10.1021/acsinfecdis.3c00063. Subject of Research. Cells. Article Publication Date. 2-Aug-2023. Disclaimer: AAAS and EurekAlert! are not ...
DOI. 10.1021/acsinfecdis.3c00063. Subject of Research. Cells. Article Publication Date. 2-Aug-2023. Share12 Tweet8Share2ShareShareShare2 ...
10.1021/acsinfecdis.3c00063. Article Title. Peptidomimetic Oligomers Targeting Membrane Phosphatidylserine Exhibit Broad Antiviral Activity ...
... 10.1021/acsinfecdis.3c00063. For more of the latest research news, register for our upcoming meeting, ACS Fall 2023. Journalists and public ...
doi.org/10.1021/acsinfecdis.3c00063. Be the first to rate this article. Posted in: Medical Science News | Medical Research News | Disease ...
At all concentrations of MXB. ACS Infectious Diseases pubs.acs.org/journal/aidcbc. Article https://doi.org/10.1021/acsinfecdis.3c00063. ACS ...
ACS Infectious Diseases, 2023; DOI: 10.1021/acsinfecdis.3c00063. Cite This Page: MLA; APA; Chicago. New York University. "Novel molecules ...
PT
NC
A
JM
PU
JH
DD
MS
OF
GP
CB
NH
GT
JM
J
JS
PP
RP